Roche's Rapid Blood Test Could Revolutionize Heart Attack Detection

A new blood test from Roche could help save lives by detecting heart attacks faster and more accurately. The test, which works like a COVID-19 rapid test, picks up tiny amounts of troponin—a protein released when the heart is damaged. Early detection is crucial, as every minute counts when treating heart attacks.

The Roche-developed test can spot troponin in the blood just one hour after symptoms begin. This makes it far quicker than many current methods, where heart attacks sometimes go unnoticed or are diagnosed too late. The test's sensitivity allows it to catch even low levels of the protein, giving a clearer warning of a possible heart problem.

Unlike traditional lab tests, this one can be used outside hospitals. Ambulances, remote clinics, and even patients at home could use it, particularly in areas far from medical services. Swiss hospitals are set to start using the test this spring.

Results appear within minutes, showing whether troponin levels exceed a critical threshold. If they do, it signals a likely heart attack, prompting faster treatment. Emergency teams could then act sooner, improving survival chances.

The test's portability and speed could change how heart attacks are handled, especially in remote or urgent settings. Swiss hospitals will roll it out in the coming months, with potential for wider use in the future. Earlier and more reliable detection may help reduce delays in life-saving care.